Eczema was moderate or severe in 51 studies, mild to moderate in 16 studies, mild to severe in 3 studies, and 34 studies did not report severity. Approximately half of the studies were funded by ...

Medically reviewed by William Truswell, MD Eczema is a long-term condition where an overactive immune response causes skin inflammation (swelling) and irritation. Eczema leads to dry, itchy patches of ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural ...

Ice cubes or packs are a quick way to bring down inflammation, lower your body temperature, and numb irritated areas. Between ...

New research published in Current Issues in Pharmacy and Medical Sciences found that a hemp seed oil-based topical emulsion ...

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the ...

The FDA has approved Incyte's Opzelura cream for atopic dermatitis, commonly called eczema, becoming the first and only topical JAK inhibitor registered in the US. Opzelura (ruxolitinib) – which ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A focused update to AAD’s adult AD guidelines recommends tapinarof, roflumilast, lebrikizumab, and nemolizumab based on ...

Antihistamines: Oral histamine-blocking medications help to reduce eczema-related symptoms caused by triggers like environmental allergies. Topical steroid creams and ointments: A healthcare provider ...